In Vivo CRO Market Size, Share & Trends Analysis Report By Type (Rodent, Non-Rodent), By GLP Type (Non-GLP, GLP Toxicology), By Indication (Pain Management, Oncology), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030
- Report ID: GVR-1-68038-011-8
- Number of Pages: 275
- Format: Electronic (PDF)
- Historical Range: 2018 - 2020
- Industry: Healthcare
Market Segmentation
- In Vivo CRO Market Type Outlook (Revenue, USD Million, 2018 - 2030)
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- In Vivo CRO Market GLP Type Outlook (USD Million, 2018 - 2030)
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- In Vivo CRO Market Indication Outlook (USD Million, 2018 - 2030)
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- In Vivo CRO Market Regional Outlook (Revenue, USD Million, 2018 - 2030)North America
- North America
- North America In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- North America In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- North America In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- U.S.
- U.S. In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- U.S. In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- U.S. In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- U.S. In Vivo CRO Market, By type
- Canada
- Canada In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Canada In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Canada In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Canada In Vivo CRO Market, By type
- North America In Vivo CRO Market, By type
- Europe
- Europe In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Europe In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Europe In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- U.K.
- U.K. In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- U.K. In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- U.K. In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- U.K. In Vivo CRO Market, By type
- Germany
- Germany In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Germany In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Germany In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Germany In Vivo CRO Market, By type
- France
- France In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- France In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- France In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- France In Vivo CRO Market, By type
- Italy
- Italy In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Italy In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Italy In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Italy In Vivo CRO Market, By type
- Spain
- Spain In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Spain In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Spain In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Spain In Vivo CRO Market, By type
- Europe In Vivo CRO Market, By type
- Asia Pacific
- Asia Pacific In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Asia Pacific In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Asia Pacific In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Japan
- Japan In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Japan In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Japan In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Japan In Vivo CRO Market, By type
- China
- China In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- China In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- China In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- China In Vivo CRO Market, By type
- India
- India In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- India In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- India In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- India In Vivo CRO Market, By type
- Australia
- Australia In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Australia In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Australia In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Australia In Vivo CRO Market, By type
- South Korea
- South Korea In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- South Korea In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- South Korea In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- South Korea In Vivo CRO Market, By type
- Asia Pacific In Vivo CRO Market, By type
- Latin America
- Latin America In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Latin America In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Latin America In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Brazil
- Brazil In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Brazil In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Brazil In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Brazil In Vivo CRO Market, By type
- Mexico
- Mexico In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Mexico In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Mexico In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Mexico In Vivo CRO Market, By type
- Argentina
- Argentina In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Argentina In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Argentina In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Argentina In Vivo CRO Market, By type
- Colombia
- Colombia In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Colombia In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Colombia In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Colombia In Vivo CRO Market, By type
- Latin America In Vivo CRO Market, By type
- Middle East & Africa
- Middle East & Africa In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Middle East & Africa In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Middle East & Africa In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- South Africa
- South Africa In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- South Africa In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- South Africa In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- South Africa In Vivo CRO Market, By type
- Saudi Arabia
- Saudi Arabia In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- Saudi Arabia In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- Saudi Arabia In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- Saudi Arabia In Vivo CRO Market, By type
- UAE
- UAE In Vivo CRO Market, By type
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
- Rodent
- UAE In Vivo CRO Market, By GLP Type
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- UAE In Vivo CRO Market, By Indication
- Autoimmune/inflammation conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable bowel syndrome
- Others
- Pain management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Syngeneic model
- Patient-derived xenograft
- Xenograft
- Others
- CNS conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle regeneration
- Others
- Diabetes
- Obesity
- Others
- Autoimmune/inflammation conditions
- UAE In Vivo CRO Market, By type
- Middle East & Africa In Vivo CRO Market, By type
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
